These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 18080035)
1. Biological agents targeting interleukin-18. Jelusic M; Lukic IK; Batinic D Drug News Perspect; 2007 Oct; 20(8):485-94. PubMed ID: 18080035 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 as a new therapeutic target for immune-mediated diseases. Monteleone G; Pallone F; Macdonald TT Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319 [TBL] [Abstract][Full Text] [Related]
3. Human anti-human IL-18 antibody recognizing the IL-18-binding site 3 with IL-18 signaling blocking activity. Hamasaki T; Hashiguchi S; Ito Y; Kato Z; Nakanishi K; Nakashima T; Sugimura K J Biochem; 2005 Oct; 138(4):433-42. PubMed ID: 16272137 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 and the treatment of rheumatoid arthritis. Dinarello CA Rheum Dis Clin North Am; 2004 May; 30(2):417-34, ix. PubMed ID: 15172050 [TBL] [Abstract][Full Text] [Related]
5. The impact of biological agents interfering with receptor/ligand binding in the immune system. Cianci R; Cammarota G; Raducci F; Pandolfi F Eur Rev Med Pharmacol Sci; 2005; 9(6):305-14. PubMed ID: 16479734 [TBL] [Abstract][Full Text] [Related]
6. Targeting interleukin-21 in inflammatory diseases. Sarra M; Franzè E; Pallone F; Monteleone G Expert Opin Ther Targets; 2011 Jun; 15(6):695-702. PubMed ID: 21391901 [TBL] [Abstract][Full Text] [Related]
7. Role of IL-15 in immune-mediated and infectious diseases. Di Sabatino A; Calarota SA; Vidali F; Macdonald TT; Corazza GR Cytokine Growth Factor Rev; 2011 Feb; 22(1):19-33. PubMed ID: 21074481 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 7 receptor alpha as a potential therapeutic target in transplantation. Racapé M; Vanhove B; Soulillou JP; Brouard S Arch Immunol Ther Exp (Warsz); 2009; 57(4):253-61. PubMed ID: 19585222 [TBL] [Abstract][Full Text] [Related]
10. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418 [TBL] [Abstract][Full Text] [Related]
11. Induction, function and regulation of IL-17-producing T cells. Mills KH Eur J Immunol; 2008 Oct; 38(10):2636-49. PubMed ID: 18958872 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929 [TBL] [Abstract][Full Text] [Related]
13. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review. Olejniczak K; Kasprzak A Med Sci Monit; 2008 Oct; 14(10):RA179-89. PubMed ID: 18830208 [TBL] [Abstract][Full Text] [Related]
14. Interleukin 5 in the link between the innate and acquired immune response. Takatsu K; Kouro T; Nagai Y Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596 [TBL] [Abstract][Full Text] [Related]
15. Perspectives in immunopharmacology: the future of immunosuppression. Boraschi D; Penton-Rol G Immunol Lett; 2014 Oct; 161(2):211-5. PubMed ID: 24333342 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-23: immunological roles and clinical implications. Tan ZY; Bealgey KW; Fang Y; Gong YM; Bao S Int J Biochem Cell Biol; 2009 Apr; 41(4):733-5. PubMed ID: 18725317 [TBL] [Abstract][Full Text] [Related]